Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Novel inhaled combination powders for respiratory infections

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: ZHOU, Qi (Tony) (The University of Sydney, Faculty of Pharmacy, Sydney, Australia)
  • Co-author(s): Gengenbach, Thomas (CSIRO Materials Science and Engineering, Melbourne, Australia)
    Denman, John (University of South Australia, Adelaide, Australia)
    Yu, Heidi (Monash University, Melbourne, Australia)
    Li, Jian (Monash University, Melbourne, Australia)
    Chan, Hak-Kim (The University of Sydney, Sydney, Australia)
  • Abstract:

    Background: For many respiratory infections caused by multidrug-resistant Gram-negative bacteria, colistin is the only effective antibiotics despite its nephrotoxicity. Inhaled therapy of colistin with a synergistic antimicrobial component of rifampicin may offer better therapeutic efficacy and reduce adverse effects.
    Aims: To develop a novel..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses